Efficacy of Trastuzumab + Cisplatin Combined with Irinotecan on the Quality of Life of Patients with Advanced Her-2 Positive Gastric Cancer

Table 5

Comparison of the 1-year survival rate of the two groups of patients.

Groups	n	Number of survived	Survival rate (%)
Control group	60	25	41.67
Joint group	60	26	43.33
X^2		0.034
		0.853